UK markets closed

Guerbet SA (0ELV.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
16.56-0.30 (-1.78%)
At close: 05:56PM GMT
Full screen
Previous close16.86
Open16.84
Bid0.00 x N/A
Ask0.00 x N/A
Day's range16.50 - 16.84
52-week range16.50 - 16.84
Volume1,107
Avg. volumeN/A
Market cap2.067M
Beta (5Y monthly)0.81
PE ratio (TTM)0.06
EPS (TTM)2.58
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Guerbet: Guerbet announces a change in governance for its Artificial Intelligence projects

    Guerbet announces a change in governance for its Artificial Intelligence projects Villepinte, November 3rd, 2022: Guerbet today announced an agreement with Merative, formalizing the termination of their collaboration signed in July 2018. Guerbet today announced an agreement with Merative formalizing the termination of their collaboration initiated in July 2018. This partnership aimed to design, develop and market software solutions to help diagnose and monitor liver and prostate cancers. The ter

  • Globe Newswire

    Guerbet: Revenue at September 30, 2022

    Revenue on September 30, 2022 Faster growth in Q3 2022 Revenue: +5.1% at CER1 (€187 million)Very dynamic activity in Asia (+18.4%) and within MRI (+17.3%)Cumulative revenue at 9 months: +0.8% at CER (€569.2 million) Update of 2022 financial targets Impact of prioritizing EluciremTM production at the Raleigh plantLike-for-like revenue growth below 2% at CER,2022 EBITDA margin between 13% and 14% (excluding extraordinary costs to optimize the operating structure and change the sales model in China

  • Globe Newswire

    Guerbet obtains one million euros of public funding from Bpifrance (France 2030 investment plan) for a project developing artificial intelligence for the early detection of pancreatic cancer

    Guerbet obtains one million euros of public funding from Bpifrance (France 2030 investment plan) for a project developing artificial intelligence for the early detection of pancreatic cancer Villepinte, 26 September 2022 – 18:00: Guerbet (GBT) obtains one million euros of public funding through a call for projects concerning the acceleration strategy in digital health via the France 2030 investment plan. The early diagnosis of pancreatic cancer is a major public health concern. The presentation